Ligand-Binding Assays in the 21st Century Laboratory: Recommendations for an Automated Data Interchange Process
Journal Title: The AAPS Journal - Year 2012, Vol 14, Issue 1
Abstract
One useful concept that is aligned with the idea of an automated data interchange process is the Globally Unique ID (GUID), also known as a Universally Unique Identifier. These special purpose identifiers are 32-character hexadecimal strings which enable computerized systems to uniquely identify a single physical entity. In the context of LBAs, GUIDs could be used to describe samples, child samples, and sample-replicates as the physical samples and/or tubes progress through clinical study conduct from central laboratory, to doctor’s office, to bioanalytical laboratory, to clinical data management group, to biostatistics, and finally to submission to regulatory authorities. GUIDs do not require central coordination and could be used to identify samples uniquely. This has practical utility because the bioanalytical laboratory receives samples from multiple sample sources such as pharmaceutical companies, other departments in the same company, universities conducting clinical trials, CROs, and central laboratories, each of which may have their own computerized system with its own barcode numbering schemes. It can be visualized that systems may have to deal with multiple GUIDs: one generated by itself as well as other(s) imported during a prior sample transfer process. Thus, the ability to exchange multiple GUIDs from one system to another represents a potential breakthrough in developing a global, universal sample exchange mechanism.
Authors and Affiliations
Sheldon S. Leung, Joel Usansky, Robert Lynde, Theingi Thway, Robert Hendricks, David Rusnak
Keywords
Related Articles
- EP ID EP681197
- DOI 10.1208/s12248-011-9319-0
- Views 87
- Downloads 0
Metabolism of GTI-2040, a phosphorothioate oligonucleotide antisense, using ion-pair reversed phase high performance liquid chromatography (HPLC) coupled with electrospray ion-trap mass spectrometry
GTI-2040 is a 20-mer phosphorothioate oligonucleotide, which is complementary to the messenger ribonucleic acid (mRNA) of the R2 subunit of ribonucleotide reductase. This study characterized both the in vivo and in vitro...
Biomaterials/Tissue Interactions: Possible Solutions to Overcome Foreign Body Response
In recent years, a variety of biomaterial implantable devices has been developed. Of particular significance to pharmaceutical sciences is the progress made on the development of drug/implantable device combination produ...
Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson’s disease
Parkinson’s disease (PD) is a debilitating movement disorder resulting from a progressive degeneration of the nigrostriatal dopaminergic pathway and depletion of neurotransmitter dopamine in the striatum. Molecul...
Human Cannabinoid 1 GPCR C-Terminal Domain Interacts with Bilayer Phospholipids to Modulate the Structure of its Membrane Environment
G protein-coupled receptors (GPCRs) play critical physiological and therapeutic roles. The human cannabinoid 1 GPCR (hCB1) is a prime pharmacotherapeutic target for addiction and cardiometabolic disease. Our prior biophy...
Population Pharmacokinetics of Cyclosporine in Transplant Recipients
A number of classical pharmacokinetic studies have been conducted in transplant patients. However, they suffer from some limitations, for example, (1) the study design was limited to intense blood sampling in small group...